Tiotropium use in patients with COPD exacerbation improves airflow limitation and decreases health resource utilization

Tiotropium use in patients with chronic obstructive pulmonary disease (COPD) exacerbation led to decreased health resource utilization (HRU) and improved airflow limitation, according to a randomized, double-blind, multicenter, parallel group study published in the European Respiratory Journal.

Related Content
© 2023 MJH Life Sciences

All rights reserved.